Stockreport

Alphamab Oncology Reports 2024 Interim Results and Business Highlights [Yahoo! Finance]

ArriVent BioPharma, Inc.  (AVBP) 
PDF Financial Summary For the six months ended June 30, 2024 , we recorded total revenue of RMB 173.56 million , an increase of 27.18% compared with the first half of 202 [Read more]